The pharmaceutical segment led growth, generating Rs. 337 crore in revenue, while the crop protection business contributed Rs. 157 crore
Bayer remains a key partner in Ginkgo Bioworks’ growing agricultural biologicals platform
Hikal has reported total income of Rs. 381.4 crores during the period ended June 30, 2025
The company received one observation in the Form-483
In Q4 FY25, our pharmaceutical business reported revenue growth of 20% to Rs 351 crore and EBIT growth of 65% to Rs 55 croe, on QoQ basis
A new weapon in the global fight against malaria
The stable raw materials prices, focused cost improvement initiatives and intensified customer acquisitions helped the company to improve its margin profile
In Q2 FY25, our crop protection segment reported revenue of Rs. 159 crore, with an EBIT margin of 5%
Critical resources will help Genvor to grow and scale biological crop protection products and innovative trait technologies
Signs MoU with the Govt. of Gujarat at Vibrant Gujarat Summit
Subscribe To Our Newsletter & Stay Updated
